# China NMPA Inspection - Guangzhou Meihui International Biotechnology Co., Ltd. - September 08, 2023

Source: https://www.globalkeysolutions.net/records/china_inspection/guangzhou-meihui-international-biotechnology-co-ltd/9ed58510-c242-45c1-9d9a-3ab96c39b677/
Source feed: China

> China NMPA unannounced inspection for Guangzhou Meihui International Biotechnology Co., Ltd. published September 08, 2023. The National Medical Products Administration (NMPA) released Announcement No. 44 of 2023 on September 7, 2023, detailing the outcomes of unannounced i

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement No. 44 of 2023 from the National Medical Products Administration regarding the results of unannounced inspections of companies including Guangzhou Zongdu International Biotechnology Co., Ltd.
- Company Name: Guangzhou Meihui International Biotechnology Co., Ltd.
- Publication Date: 2023-09-08
- Product Type: cosmetics
- Summary: The National Medical Products Administration (NMPA) released Announcement No. 44 of 2023 on September 7, 2023, detailing the outcomes of unannounced inspections conducted on six cosmetics manufacturers. Guangzhou Zongdu International Biotechnology Co., Ltd. was among the enterprises identified for non-compliance. While specific inspection dates were not provided, the findings were published on September 8, 2023.

The inspections revealed that these companies violated crucial regulatory frameworks, including the "Cosmetics Supervision and Management Regulations" and the "Cosmetics Production Quality Management Standards." These breaches indicate deficiencies in their manufacturing processes and overall quality control systems, potentially jeopardizing public safety.

In response, the NMPA has instructed the Guangdong Provincial Drug Administration to address these suspected illegal activities according to the law. Consequently, the implicated companies have been ordered to suspend their production and operations, initiate comprehensive rectification measures, and are now subject to an ongoing official investigation by the Guangdong Provincial Drug Administration. This demonstrates the NMPA's dedication to ensuring rigorous compliance and consumer protection within the cosmetics sector.

Company: https://www.globalkeysolutions.net/companies/guangzhou-meihui-international-biotechnology-co-ltd/babe9ac3-94fb-4dbb-a32d-c95b6ceb1b04/